Skip to Content Skip to Search

Company

A new era for human health

GSK is a global biopharma company with the ambition and purpose to unite science, technology and talent to get ahead of disease together.

Purpose, strategy and culture
A signal for change
Close Video

Scroll to explore

Our strategy

We make innovative vaccines and specialty medicines to prevent and treat disease. Our R&D focuses on the science of the immune system, human genetics and advanced technologies.

Our R&D focus is on four therapeutic areas: infectious diseases, HIV, oncology, and immunology.

Infectious diseases
1 in 3
of us will be affected by shingles in our lifetime
Go to infectious diseases
HIV
38m
people are living with HIV worldwide
Go to HIV
Oncology
~10m
people died from cancer in 2020, making it a leading cause of death worldwide
Go to oncology
Immunology
25yrs
of leading research to help people with inflammatory conditions
Go to immunology
Behind the science

Discover how we're getting ahead

R&D scientist walking through chemistry smart lab.

Unlocking the power of the immune system to get ahead of hepatitis B

Tackling tomorrow’s health challenges today
GSK quality lab operator engaged in focussed task.

How vaccine science can help tackle antimicrobial resistance

The 40 year fight against HIV
Nextgen Header

How the next generation of immuno-oncology could help us get ahead of cancer
Scientist inspecting vial

1.4 million reasons to get ahead of gynaecologic cancers
Lab worker adjusting glasses

Digital twin: using advanced technology to accelerate vaccine development
GSK quality lab team members collaborating and engaged in focussed task

What if remission were the target of lupus care?

Synthetic Lethality: accelerating precision cancer treatments
UK data centre at Stevenage - building 16

Tech for T-cells single cell RNA seq measures shifts in immune cells to pinpoint causes of disease
Read our magazine
Life at GSK

How we help people thrive 

Studio portrait - light background - 8

Culture

At GSK, culture is something we all own. It’s powered by the little things GSK people do every day to help us get ahead of disease together. It drives delivery of our strategy and makes GSK a place people can thrive. Being ambitious for patients, accountable for impact and making sure we always do the right thing is how we deliver for patients, shareholders, and of course the people who work here.

The Code     Purpose, strategy and culture

Man smiling

Growth

Helping people grow professionally and personally is fundamental to GSK. Because we know when individuals grow, our company grows too. Everyone at GSK is encouraged to drive their development through a blend of on-the-job experiences, plus best-in-class formal and informal learning.

Life at GSK

Man smiling

Diversity, equity and inclusion

We’re dedicated to diversity, equity and inclusion in what we do and how we do it. Because it's the right thing to do and it helps us perform better. That’s why we focus on recognising and making the most of our differences and encourage everyone to bring their authentic selves to work. We make sure everyone gets equal opportunities and we’re fully committed to ensuring our workforce reflects the communities in which we work.

Diversity, equity and inclusion

Scientists conversing over skeletal formulae

Wellbeing

We prioritise personal wellbeing so that our people can thrive both in and out of work. We achieve this by fostering a healthy and safe working space for them to succeed and grow. Above all, working at GSK means working with colleagues, friends and managers who support, motivate and care for one another every step of the way.

Life at GSK

Careers at GSK
icon

Outstanding people

Mugdha 1280
INNOVATING TOGETHER 2022
Meet Mugdha: working together to help more patients
GSK Precisionpoint 1280X720 Trust Tim (1)
WORKING TOGETHER
Meet Tim: valuing neurodiversity in Global Health
GSK Precisionpoint 1280X720 Trust Fiona
WORKING TOGETHER
Meet Fiona: improving health and wellbeing through nature
GSK Precisionpoint 1280X720 Trust Andy
WORKING TOGETHER
Meet Andy: how a life-changing diagnosis changed his career
GSK Twist Small 1280X720 Employee Alison
THRIVING TOGETHER
Meet Alison: taking pride in working for GSK
Pal 1280
INNOVATING TOGETHER 2022
Meet Pal: combining the power of genetics and genomics
View all series

In the spotlight

INVESTORS

GSK delivers strong Q2 2022 sales of £6.9 billion

MEDIA

Completion of the demerger of Haleon and share consolidation of GSK

INVESTORS

Access all documents and information relating to the demerger

INVESTORS

We announced our second quarter 2022 results on Wednesday 27 July.

View latest results

Continue to Company

Back to top